genOway S.A.
ALGEN.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €0 | €36,932 | €38,593 | €40,663 |
| - Cash | €2,130 | €4,953 | €4,862 | €4,260 |
| + Debt | €14,489 | €5,575 | €6,375 | €7,233 |
| Enterprise Value | €12,360 | €37,555 | €40,107 | €43,636 |
| Revenue | €9,603 | €11,349 | €10,710 | €10,714 |
| % Growth | -15.4% | 6% | -0% | – |
| Gross Profit | €0 | €7,814 | €6,912 | €19,201 |
| % Margin | 0% | 68.9% | 64.5% | 179.2% |
| EBITDA | €382 | €443 | €327 | €5,712 |
| % Margin | 4% | 3.9% | 3.1% | 53.3% |
| Net Income | €143 | €1,125 | €706 | €550 |
| % Margin | 1.5% | 9.9% | 6.6% | 5.1% |
| EPS Diluted | 0.015 | 0.11 | 0.076 | 0.062 |
| % Growth | -86.8% | 44.5% | 22.3% | – |
| Operating Cash Flow | €0 | €0 | €3,251 | €0 |
| Capital Expenditures | €0 | €0 | -€542 | €0 |
| Free Cash Flow | €0 | €0 | €2,709 | €0 |